scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...883754D |
P356 | DOI | 10.1371/JOURNAL.PONE.0083754 |
P932 | PMC publication ID | 3877089 |
P698 | PubMed publication ID | 24391821 |
P5875 | ResearchGate publication ID | 259589356 |
P50 | author | Colin Sumners | Q64025382 |
P2093 | author name string | Ming Li | |
Yanling Zhang | |||
Yi Zhang | |||
Zhi Huang | |||
Hongyan Du | |||
Hongwei Li | |||
Baihong Chen | |||
Yang Fei | |||
Andrew Li | |||
Jinlong Li | |||
Suihai Wang | |||
Feilong Jie | |||
Nana Pei | |||
Zhibing Liang | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma | Q28211260 | ||
The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy | Q28281648 | ||
Angiotensin II-inducible smooth muscle cell apoptosis involves the angiotensin II type 2 receptor, GATA-6 activation, and FasL-Fas engagement | Q28568716 | ||
Highly specific expression of luciferase gene in lungs of naïve nude mice directed by prostate-specific antigen promoter | Q30437533 | ||
Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. | Q31065290 | ||
Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation | Q31805054 | ||
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice | Q33534042 | ||
AAV's anatomy: roadmap for optimizing vectors for translational success | Q33659389 | ||
Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis. | Q52546658 | ||
Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation | Q74605937 | ||
Angiotensin II induces apoptosis in intestinal epithelial cells through the AT2 receptor, GATA-6 and the Bax pathway | Q84549479 | ||
Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients | Q34008631 | ||
Adeno-associated virus vectorology, manufacturing, and clinical applications | Q34172314 | ||
Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells | Q34280097 | ||
Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis | Q34731369 | ||
Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells | Q35097995 | ||
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B | Q35691659 | ||
Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth | Q36594271 | ||
Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival | Q36613817 | ||
Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury | Q36748599 | ||
Clinical gene therapy using recombinant adeno-associated virus vectors | Q37140649 | ||
Gene therapy clinical trials worldwide to 2012 - an update. | Q38077166 | ||
The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells | Q38299038 | ||
Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis | Q39360166 | ||
RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway | Q39578288 | ||
Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells | Q39765517 | ||
Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells | Q40353409 | ||
Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities. | Q40367712 | ||
Intronic enhancement of angiotensin II type 2 receptor transgene expression in vitro and in vivo | Q40381528 | ||
Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination | Q40438044 | ||
Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis. | Q40542869 | ||
Differential regulation of in vivo angiogenesis by angiotensin II receptors | Q40620209 | ||
Angiotensin II receptors and angiotensin II receptor antagonists. | Q40846126 | ||
Molecular and cellular mechanism of angiotensin II-mediated apoptosis | Q40980902 | ||
Potentiation of the antihypertensive action of losartan by peripheral overexpression of the ANG II type 2 receptor. | Q42503774 | ||
Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union | Q42516930 | ||
Dysregulation of apoptosis in hepatocellular carcinoma cells | Q43166036 | ||
Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis | Q43167619 | ||
Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis | Q44018962 | ||
Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors | Q44669197 | ||
Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors | Q44725147 | ||
Arrestins block G protein-coupled receptor-mediated apoptosis | Q44820320 | ||
Imaging transgene expression in live animals | Q45198958 | ||
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth | Q45214758 | ||
Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice. | Q45261608 | ||
Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: involvement of transforming growth factor-beta-dependent cell growth attenuation | Q46685681 | ||
Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice | Q47752119 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
overexpression | Q61643320 | ||
P304 | page(s) | e83754 | |
P577 | publication date | 2013-12-31 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo | |
P478 | volume | 8 |
Q38814333 | AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray |
Q36473924 | Adenovirus-Mediated Angiotensin II Type 2 Receptor Overexpression Inhibits Tumor Growth of Prostate Cancer In Vivo |
Q33784943 | Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer |
Q40939536 | Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients |
Q36307866 | Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor |
Q55127228 | Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma. |
Q28078113 | Local ablative treatments for hepatocellular carcinoma: An updated review |
Q38937272 | Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells |
Q89640256 | Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy |
Q36400573 | Small-molecule AT2 receptor agonists |
Q64098694 | Spontaneous Regression of Hepatocellular Carcinoma and Review of Reports in the Published English Literature |
Q51326132 | Support for involvement of the renin-angiotensin system in dysplastic Barrett's esophagus. |
Q92573164 | Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma |
Q46486488 | The ROS derived mitochondrial respirstion not from NADPH oxidase plays key role in Celastrol against angiotensin II-mediated HepG2 cell proliferation |
Search more.